Health Care/Hospital
Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies
CAMBRIDGE, Mass. and SUZHOU, China, Jan. 7, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the first closing of an oversubscribed$53.5 million Series B+ fina...
2021-01-07 20:31
2631
CORI Innolab Launches CORI Super Recharge 96(TM): Rechargeable Super Mask on Kickstarter
SINGAPORE, Jan. 7, 2021 /PRNewswire/ -- CORI Innolab (Formerly known as CORI Traveller), the makers ofCORI SuperMask™ and SuperMask™ Active, has launched an ultra-breathable, rechargeable high-performance mask that allows users to retain the mask filtration efficacy through triboelectric mechanis...
2021-01-07 20:00
1518
IACTA Pharmaceuticals and Pharmaleads to Develop the World's First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain
- Ocular Pain, a $10+ billion global market, with significant unmet medical need - License agreement aims to accelerate global development of DENKIs, leveraging expertise and resources of both companies IRVINE, California, PARIS, HONG KONG, Jan. 7, 2021 /PRNewswire/ -- IACTA Pharmaceuticals, Inc...
2021-01-07 20:00
2295
VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China
SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company committed to the treatment of endocrine-related diseases, introducing the world's leading treatment methods and drugs into theChina market and hoping to provide more Chinese patients quick access to the world's most a...
2021-01-07 18:45
1487
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics
- Adds to Merck's lipid manufacturing expertise, providing an integrated offering across mRNA value chain - AmpTec's differentiated polymerase chain reaction (PCR)-based technology has shown to have advantages over other technologies for mRNA manufacturing - Diagnostics business focused on produ...
2021-01-07 17:00
4142
Qiming Venture Partners' Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange
SHANGHAI, Jan. 7, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company APT Medical (SHSE: 688617) today successfully listed on the Science and Technology Innovation Board (the STAR Board) of Shanghai Stock Exchange. The issue price isCNY 74.46 per share. The stock opened at CNY 221.73 ...
2021-01-07 16:13
3671
GEN inCode Appoints New Chairman
OXFORD, England, Jan. 7, 2021 /PRNewswire/ -- GEN inCode UK Limitedthe privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the appointment of Bill Rhodes as non-executive Chairman of the Company, effective 1 Ja...
2021-01-07 15:00
5418
KAIST Mobile Clinic Module to Fill Negative Pressure Ward Shortage
DAEJEON, South Korea, Jan. 6, 2021 /PRNewswire/ -- A team from KAIST has developed a low-cost and ready-for-rapid-production negative pressure room called a Mobile Clinic Module (MCM). The MCM is expandable, moveable, and easy to store through a combination of negative pressure frames, air tents...
2021-01-07 12:00
1712
KAIST Mobile Clinic Module to Relieve Demand for Negative Pressure Beds
DAEJEON, South Korea, Jan. 6, 2021 /PRNewswire/ -- A KAIST team has developed a low-cost and ready-for-rapid-production negative pressure room called a Mobile Clinic Module (MCM). The MCM expects to quickly meet the high demand for negative pressure beds in the nation and eventually many other c...
2021-01-07 12:00
1516
New Thai health drink 'QminC' surges during COVID-19 pandemic
BANGKOK, Jan. 7, 2021 /PRNewswire/ -- Four months after its launch in Thailand , an innovative health drink fortified with curcumin extracted from the turmeric plant's rootstalks, has found its way on to the shelves of more than 15,000 modern trade retail outlets and almost 500,000 mom and pop s...
2021-01-07 11:31
7592
CGTN: What drives China's success in 2020
BEIJING, Jan. 6, 2021 /PRNewswire/ -- Facing unprecedented challenges brought by COVID-19 and the complex changes in external environment, the Communist Party ofChina (CPC) Central Committee with Comrade Xi Jinping at the core has ledChina to achieve substantial progress in 2020. &nb...
2021-01-06 23:16
3893
Bioworkshops successfully passed EU QP audit
SUZHOU, China, Jan. 6, 2021 /PRNewswire/ -- In November 2020, Bioworkshops passed a European drug Qualified Person audit (QP audit) for manufacture of clinical drug substance and drug product at their Suzhou site. The ratification of compliance to EU GMP comes within a month of obtaining a Drug M...
2021-01-06 22:00
1643
Everest Medicines Announces CTA Approval by China NMPA for Phase 3 Trial of Sacituzumab Govitecan-Hziy for Metastatic Urothelial Cancer
SHANGHAI, Jan. 6, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, today announced th...
2021-01-06 21:54
6094
Everest Medicines Initiates Submission of New Drug Application in Singapore for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer
SHANGHAI, Jan. 6, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts of Asia, announced today th...
2021-01-06 21:52
6376
VolitionRx Limited Awarded an Additional $4 Million in Non-Dilutive Funding
AUSTIN, Texas, Jan. 6, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it has been awarded additional non-dilutive funding totaling approximately$4 million from the Walloon Region and Namur Invest,Belgium. To date, Agencies from the Walloon Region have a...
2021-01-06 21:25
9569
INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Vulvar Dysplasia Caused by HPV-16/18
- DNA immunotherapy candidate VGX-3100 demonstrated clinically significant reduction of HPV-16/18-associated precancerous vulvar lesions in 63% of treated participants six months after treatment - Phase 2 results indicate that VGX-3100 can be a safe, tolerable and efficacious adjunct to current ...
2021-01-06 21:00
3869
RedHill Biopharma's RHB-204 Granted FDA Fast Track Designation for NTM Disease
TEL AVIV, Israel and RALEIGH, NC, Jan. 6, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-01-06 20:24
5799
Eleva Secures up to EUR 60 million to Advance a Drug Candidate, Appoints New Board Member
FREIBURG, Germany, Jan. 6, 2021 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, has secured up toEUR 60 million in funding from Zukunftsfonds Heilbronn (ZFHN). The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further investment from ven...
2021-01-06 17:00
1770
Yiling Pharma expects to double its YoY net profit in 2020
SHIJIAZHUANG, China, Jan. 6, 2021 /PRNewswire/ -- Yiling Pharmaceutical, a Shenzhen stock market listed enterprise (002603.SZ), has recently published its 2020 earnings projection. The yearly net profit belonging to its shareholders is anticipated to be between 1.152 billion Chinese yuan and 1.27...
2021-01-06 16:55
6940
Seegene's COVID-19 test with saliva sample collection feature now available in Europe
SEOUL, South Korea, Jan. 6, 2021 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Tuesday that it has CE-IVD marked the saliva-based testing application for Allplex™ SARS-CoV-2 Assay and Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay...
2021-01-06 16:27
1824
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 327 media titles]
2025-01-18 03:30
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 298 media titles]
2025-01-18 17:00
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 295 media titles]
2025-01-14 21:00
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44
